The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III, randomized study of daratumumab, cyclophosphamide, bortezomib and dexamethasone (DARA-VCD) induction followed by autologous stem cell transplant or DARA-VCD consolidation and daratumumab maintenance in patients with newly diagnosed AL amyloidosis.
 
Patrick Hagen
Speakers' Bureau - Bristol-Myers Squibb; Sanofi
 
Surbhi Sidana
No Relationships to Disclose
 
Terri L. Parker
No Relationships to Disclose
 
Brian Keith Walker
No Relationships to Disclose
 
Antje Hoering
Research Funding - EUSA Pharma (Inst); Hookipa Biotech (Inst)
 
Vaishali Sanchorawala
Honoraria - Abbvie; Gate Bioscience; Janssen; Janssen; Pfizer; Prothena; Prothena; Prothena
Consulting or Advisory Role - Abbvie; Caelum Biosciences; Janssen Research & Development; Proclara; Protego Biopharma; Regeneron
Research Funding - Caelum Biosciences (Inst); Celgene (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Oncopeptides (Inst); Prothena (Inst); Takeda (Inst)
 
Jeffrey A. Zonder
No Relationships to Disclose
 
Taxiarchis Kourelis
Research Funding - Novartis
 
Anita D'Souza
Consulting or Advisory Role - Janssen Oncology; Kedrion Biopharma; Pfizer; Prothena
Research Funding - Abbvie (Inst); Caelum Biosciences (Inst); Janssen Oncology (Inst); Novartis (Inst); Prothena (Inst); Regeneron (Inst); Sorrento Therapeutics (Inst)
 
Heather Jolie Landau
Consulting or Advisory Role - Abbvie/Genentech; Nexcella; Prothena
Research Funding - Alexion Pharmaceuticals (Inst); Janssen Oncology (Inst); Protego Biopharma (Inst); Prothena (Inst)
 
Adam Rosenthal
No Relationships to Disclose
 
Sikander Ailawadhi
Consulting or Advisory Role - Amgen (Inst); Beigene; BMS (Inst); Cellectar (Inst); GlaxoSmithKline; Janssen (Inst); Pharmacyclics (Inst); Regeneron; Sanofi; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Ascentage Pharma (Inst); BMS (Inst); Cellectar (Inst); GlaxoSmithKline (Inst); Janssen Biotech (Inst); Pharmacyclics (Inst); Sanofi (Inst)
 
Robert Z Orlowski
No Relationships to Disclose